Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Cuts Target Price to $286
Baird Adjusts Price Target on Labcorp to $286 From $289, Keeps Outperform Rating
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $260
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $264
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $249
Labcorp Holdings Analyst Ratings
HSBC Upgrades Labcorp Holdings(LH.US) to Buy Rating
Piper Sandler Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $240
Barclays Adjusts Price Target on Labcorp to $249 From $234, Maintains Equalweight Rating
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $262
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $260
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $249 to $289
Evercore ISI Sticks to Its Hold Rating for Laboratory (LH)
Laboratory Corp. Is Maintained at Outperform by Baird
Labcorp Holdings Analyst Ratings
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $260
Laboratory Corp. Is Maintained at Equal-Weight by Barclays
Labcorp Holdings Analyst Ratings
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Cuts Target Price to $234
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $260